China SXT Pharmaceuticals...

2.74
0.02 (0.74%)
At close: Mar 28, 2025, 3:56 PM
2.73
-0.24%
After-hours: Mar 28, 2025, 07:33 PM EDT

China SXT Pharmaceuticals Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -3.1M -5.93M -5.74M -2.75M -10.29M 1.54M 1.19M 1.19M 141.54K
Depreciation & Amortization 203.25K 250.16K 320.01K 345.41K 331.84K 180.92K 129.44K 99.23K 88.96K
Stock-Based Compensation 352.1K 554.57K 2.33M n/a n/a n/a n/a n/a n/a
Other Working Capital 159.41K 83.91K 1.28M -506.08K 1.5M 660.63K -467.63K 1.04M 1.09M
Other Non-Cash Items 996.69K 408.69K 1.12M 1.62M 3.35M 66.89K -2 1.44M 1.34M
Deferred Income Tax n/a 3.23M 328.15K -192.68K -101.72K -7.72K -5.85K n/a n/a
Change in Working Capital -381.56K 1.42M 1.9M -1.61M 1.95M -1.54M 608.99K -991.33K -58.63K
Operating Cash Flow -1.93M -80.76K 268.29K -1.32M 934.25K 239.19K 1.92M 293.04K 182.47K
Capital Expenditures -7.06K -70.68K -62.49K -93.04K -406.66K -610.09K -1.05M -186.31K -96.99K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a 1.23K
Purchase of Investments n/a n/a n/a -8.85M -3.59M n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies 33.49K 58.38K 15.58K 3.13M -1.5M -11.28K -92.42K -7.13K -36.04K
Investing Cash Flow 26.42K -12.3K -46.91K -5.81M -5.5M -610.09K -1.14M -186.31K -95.76K
Debt Repayment 1.31M 4M 2.77M -124.95K 8.8M 69.49K -314.22K n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -3.93M -3.26M -4.29M 12.53M -5.78M 2.48M n/a -50.56K -128.59K
Financial Cash Flow -2.62M 2.94M 1.6M 12.41M 3.02M 9.04M -314.22K -50.56K -128.59K
Net Cash Flow -5.29M 1.8M 2.21M 6.07M -2M 8.63M 494.68K 54.13K -43.91K
Free Cash Flow -1.94M -151.44K 205.8K -1.41M 527.59K -370.89K 869.44K 106.73K 85.48K